Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Heuschmann

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Pharmaceutics|September 28, 2023
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL TrialMichael Frey, Lukasz Smigielski, Elvira Tini, et al.
European Journal of Preventive Cardiology|February 18, 2015
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countriesKornelia Kotseva, David Wood, Dirk De Bacquer, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort studyHelge Hebestreit, Cornelia Zeidler, Christopher Schippers, et al.
Scientific Reports|February 25, 2025
Factors associated with reduction in quality of life after SARS-CoV-2 infectionChristian Neumann, Tim J Hartung, Klara Boje, et al.
Cardiovascular Diabetology|October 3, 2015
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of CardiologyViveca Gyberg, Dirk De Bacquer, Guy De Backer, et al.
European Journal of Epidemiology|October 25, 2018
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up studyDirk De Bacquer, Delphine De Smedt, Kornelia Kotseva, et al.
European Journal of Preventive Cardiology|February 12, 2019
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registryKornelia Kotseva, Guy De Backer, Dirk De Bacquer, et al.
Infection|August 2, 2023
Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE projectBerit Lange, Veronika K Jaeger, Manuela Harries, et al.
Frontiers in Medicine|September 5, 2025
Impact of bleeding and thrombosis on outcome of 945 COVID-19 VV-ECMO cases from a German registryJohannes Herrmann, Janno Schade, Patrick Meybohm, et al.
European Journal of Epidemiology|July 29, 2022
The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristicsMaximilian Schons, Lisa Pilgram, Jens-Peter Reese, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Pharmaceutics|September 28, 2023
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL TrialMichael Frey, Lukasz Smigielski, Elvira Tini, et al.
European Journal of Preventive Cardiology|February 18, 2015
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countriesKornelia Kotseva, David Wood, Dirk De Bacquer, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort studyHelge Hebestreit, Cornelia Zeidler, Christopher Schippers, et al.
Scientific Reports|February 25, 2025
Factors associated with reduction in quality of life after SARS-CoV-2 infectionChristian Neumann, Tim J Hartung, Klara Boje, et al.
Cardiovascular Diabetology|October 3, 2015
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of CardiologyViveca Gyberg, Dirk De Bacquer, Guy De Backer, et al.
European Journal of Epidemiology|October 25, 2018
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up studyDirk De Bacquer, Delphine De Smedt, Kornelia Kotseva, et al.
European Journal of Preventive Cardiology|February 12, 2019
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registryKornelia Kotseva, Guy De Backer, Dirk De Bacquer, et al.
Infection|August 2, 2023
Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE projectBerit Lange, Veronika K Jaeger, Manuela Harries, et al.
Frontiers in Medicine|September 5, 2025
Impact of bleeding and thrombosis on outcome of 945 COVID-19 VV-ECMO cases from a German registryJohannes Herrmann, Janno Schade, Patrick Meybohm, et al.
European Journal of Epidemiology|July 29, 2022
The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristicsMaximilian Schons, Lisa Pilgram, Jens-Peter Reese, et al.
Pageof 11